Ignite Creation Date:
2025-12-25 @ 12:44 AM
Ignite Modification Date:
2025-12-31 @ 5:03 PM
Study NCT ID:
NCT04379167
Status:
UNKNOWN
Last Update Posted:
2020-05-07
First Post:
2020-04-29
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 2 Clinical Study of YY-20394 in Patients With Relapsed/Refractory Follicular Lymphoma
Sponsor:
Shanghai YingLi Pharmaceutical Co. Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-12-30
Start Date Type:
ESTIMATED
Primary Completion Date:
2022-12-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2022-12-30
Completion Date Type:
ESTIMATED
First Submit Date:
2020-04-29
First Submit QC Date:
None
Study First Post Date:
2020-05-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-05-06
Last Update Post Date:
2020-05-07
Last Update Post Date Type:
ACTUAL